Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Recombinant protein fragment corresponding to a region within amino acids 1131 and 1352 of Human VEGF Receptor 3|
|Purification||Antigen affinity chromatography|
|Storage buffer||0.1M tris glycine, pH 7, with 10% glycerol|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Western Blot (WB)||1:500-1:3000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
PA5-27277 targets VEGF Receptor 3 in WB applications and shows reactivity with Human samples.
The PA5-27277 immunogen is recombinant protein fragment corresponding to a region within amino acids 1131 and 1352 of Human VEGF Receptor 3.
This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
FLT-4; FLT41; fms-like tyrosine kinase 4; fms-related tyrosine kinase 4; LMPH1A; PCL; soluble VEGFR3 variant 1; soluble VEGFR3 variant 2; soluble VEGFR3 variant 3; tyrosine-protein kinase receptor FLT4; vascular endothelial growth factor receptor 3; VEGFR3
FLT-4; FLT4; FLT41; LMPH1A; PCL; VEGFR-3; VEGFR3